The epigenetics market is projected to reach USD 4.3 Billion by 2028 from USD 1.8 Billion in 2023, at a CAGR of 18.3% during the forecast period. Market growth is largely driven growing investment in research & development and rising demand for epigenetic-based therapeutics. Epigenetics …
The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are …
The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are …
The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to …
Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, …
Epigenetics refers to the covalent modification of DNA, RNA, or protein that result in changes to the function and/or regulation of these molecules, without altering their primary sequences. Epigenetics has its applications in large number of fields including oncology, drug discovery, disease diagnosis, developmental biology …